Retatrutide – Peptide Paradise
US$ 21.82
glp-1 receptor agonist pancreatitis risk meta-analysis Agonists and GLP-1 Receptor Agonists as Treatments
Description
(2021, Jun 04)
Nat Commun 2024
However, adequate adjustment of insulin doses and close monitoring after GLP-1RA initiation may decrease this risk
July 2023
This aligns with the papers findings, where continuity of service is crucial, and the penalty for treatment interruption is high
